







































Volume 02 Issue 12-2022 21 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 02 ISSUE 12     Pages: 21-26 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705)  
OCLC – 1121105677    METADATA IF – 5.896 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 

 

 

 

 

 

 

 

 

 

 

ABSTRACT 

In order to introduce pharmaceutical care (PC) to ophthalmic patients, we studied the statistics of diseases, conducted 

an assortment analysis of drugs used in ophthalmic diseases. The analysis of the purchase of drugs was carried out, 

the index of renewal and consumption of medicines used in ophthalmic practice was considered. Based on the 

analysis, a AF model has been developed that will improve the effectiveness and safety of drug therapy, as well as 

improve the quality of life of the patient by integrating the efforts of medical, pharmaceutical specialists and patients. 

 

KEYWORDS 

Pharmaceutical care, ophthalmology, medicines, eye diseases 

INTRODUCTION 

Today, the task of optimizing the work of the 

pharmaceutical industry can be solved by improving 

the provision of the population, which can be 

implemented taking into account a large number of 

  Research Article 

 

SYSTEM MODELING OF PHARMACEUTICAL CARE IN 

OPHTHALMOLOGICAL PRACTICE AND ORGANIZATIONAL AND 

ECONOMIC JUSTIFICATION OF THE MAIN DIRECTIONS OF ITS 

IMPLEMENTATION 
 

Submission Date: December 20, 2023, Accepted Date:  December 25, 2023,  

Published Date: December 30, 2023  

Crossref doi: https://doi.org/10.37547/ajbspi/Volume02Issue12-04 

 

 

Shodmanov Shoyusuf Furkatovich 
Competitor of the Tashkent Pharmaceutical Institute, Uzbekistan 

 

Umarova Shakhnoza Ziyatovna 
Pharmaceutical Institute of Education and Research, Ph.D. prof., Uzbekistan 

 

Journal Website: 

https://theusajournals.

com/index.php/ajbspi 

Copyright: Original 

content from this work 

may be used under the 

terms of the creative 

commons attributes 

4.0 licence. 

 

https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/
https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://theusajournals.com/index.php/ajbspi
https://theusajournals.com/index.php/ajbspi


Volume 02 Issue 12-2022 22 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 02 ISSUE 12     Pages: 21-26 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705)  
OCLC – 1121105677    METADATA IF – 5.896 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

factors, and by developing the field of pharmaceutical 

services, which depends on the qualifications of 

employees and the capabilities of the organizations 

themselves [1].  Pharmaceutical care is a 

complex integrated process of cooperation, which is 

aimed at the timely detection, prevention and solution 

of problems associated with the use of medicines [2].  

The main goal of pharmaceutical care is to optimize the 

health status and quality of life of patients, as well as 

to achieve further positive clinical results [2]. 

The purpose of the study . To develop a model for 

optimizing systemic pharmaceutical care in ophthalmic 

practice. 

 

RESULTS OF THE STUDY  

 

To solve the formulated problem and in accordance 

with the goals of optimizing pharmaceutical care , a 

model was developed. 

The goal of management is to improve the AF of 

patients with ophthalmic diseases. The main result of 

the management of this model is to improve the 

quality of drug provision for ophthalmic patients. The 

developed model is characterized by the 

interconnectedness of management levels and 

functional management processes. The main part of 

the developed model includes the management of the 

pharmaceutical care system, implemented through the 

organizational and economic management 

mechanism, which is a complex of certain elements 

that provide the necessary final result. 

 

The main goal of this model includes the management 

and optimization of pharmaceutical care and has 2 

levels of its implementation: 1st level - these are 

medical organizations, starting with a visit to a doctor 

to the correct diagnosis of the disease and prescribing 

the necessary medicines, respectively, taking into 

account the patient's solvency. This stage also includes 

self-treatment of patients on the advice of friends, 

based on past experience, as well as the preferences of 

the patient himself. Stage 2 or level of pharmacy 

organizations that provide pharmaceutical assistance, 

the duty of this stage is to form a need, while studying 

consumer interaction, satisfaction, loyalty. To perform 

the above functions, both levels must study the 

treatment protocols, form a list of essential medicines. 

Both levels of organization include the professionalism 

of the staff, the patient's ability to pay, the 

effectiveness and availability of pharmacotherapy. 

Each level of management is interconnected. Outcome 

of the Pharmaceutical Care Enhancement and 

Improvement Model ( Figure 5.1) . 

For the purpose of the effective functioning of the 

proposed model, an organizational and economic 

justification of the main directions for the 

implementation of the model, which consists of 5 

stages, has been developed. 

 

Stage 1 Analysis of the state of pharmaceutical care for 

patients with problems of the eyes and adnexa. Below 

are the main components of this stage: 

- Analysis of the pharmaco-epidemiology of 

ophthalmic diseases to determine accurate 

statistics and prognosis. 

- Analysis of the range of drugs used in ophthalmic 

diseases. 

- Analysis of the volume of the pharmaceutical 

market of medicines used in ophthalmic diseases. 

- Study of demand and actual consumption of 

medicines used in ophthalmic diseases. 

 

During the first stage, we collect basic data for analysis. 

2nd stage. Organizational and economic approaches to 

the study of consumers, which consist of: 

1. Processing of statistical data of ophthalmic 

diseases for predicting morbidity. 

https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/index.php/ajbspi


Volume 02 Issue 12-2022 23 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 02 ISSUE 12     Pages: 21-26 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705)  
OCLC – 1121105677    METADATA IF – 5.896 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

2. Marketing analysis of the assortment, as well 

as graphical analysis of the results. 

3. Analysis of the volume of the pharmaceutical 

market and interpretation of the results. 

4. Assessment of the economic availability of 

medicines. 

5. Assessment of the need for medicines. 

6. Assessment of drug consumption. 

 

The economic results of this stage consist of: 

 

1. The actual spread of the disease. 

2. The total number of the range of medicines. 

3. The actual volume of import of medicines. 

4. Actual demand and consumption of medicines. 

5. Accuracy and reliability of forecasting. 

3-stage. Stage comparison: 

1. Compare the actual consumption of drugs with the 

actual size of the pharmaceutical market. 

2. Compare prescribed medicines with standards of 

care by reviewing patient history. 

The results of the 3rd stage contribute to the definition 

of need and the rational use of medicines. 

4-stage. Pharmaco -economic evaluation of therapy 

used in ophthalmic practice consists of: 

1. Conduct a systematic review of the scientific 

literature based on evidence-based medicine on clinical 

effectiveness 

2. Systematic review of scientific literature on cost-

effectiveness 

3. Analysis of the cost-effectiveness of treatment 

The results of the 4th stage contribute to the 

formation of a list of essential medicines, the 

improvement of treatment standards, as well as clinical 

recommendations, and the rational use of the state 

budget . Figure 5.2 shows a diagram of the 

organizational and economic justification model for 

the main directions of implementation. 

5-stage. The development of optimal pharmaceutical 

care for diseases of the eye and adnexa consists of: 

1. Based on the statistical processing of diseases, 

develop a program 

2. Develop a disease forecasting program 

3. Based on the forecast, determine the need for 

medicines used in ophthalmic practice 

As a result of the developed model, it is possible to 

improve pharmaceutical care for patients with 

diseases of the eyes and adnexa. 

 

https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/index.php/ajbspi


Volume 02 Issue 12-2022 24 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 02 ISSUE 12     Pages: 21-26 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705)  
OCLC – 1121105677    METADATA IF – 5.896 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 
 

Rice. 1 Model for improving pharmaceutical care for ophthalmic patients 

 

 

1 level 

Medical organization 

 

 

 

 

 

 

 

 

 

              

    

 

 

 

Level 2 

pharmacy organization 

Role of Systemic Pharmaceutical Care 

Patient with eye problem 

Outcome: Increases and improvements in the organization of pharmaceutical care 

Contacting a doctor 

1. Diagnosis of the patient 

2. Choice of rational 

pharmacotherapy 

3. The decision to take 

pharmacotherapy for p 

Advice from friends 

Self-treatment 

Past experience Patient 

preferences 

Waiting for the result of pharmacotherapy 

Professionalism of 

pharmacists 

Create demand for medicines Explore: 

1 . Consumer 

interaction 

2. Customer 

satisfaction 

3. Consumer loyalty 

Disease prevalence analysis 

Study of treatment 

protocols 

Formation of a list of 

basic medicines 

https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/index.php/ajbspi


Volume 02 Issue 12-2022 25 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 02 ISSUE 12     Pages: 21-26 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705)  
OCLC – 1121105677    METADATA IF – 5.896 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

 
Rice. 2. Organizational and economic justification of the main directions for the implementation of the model 

 

Findings 

Organizational and economic substantiation of the main directions of the model implementation

1. Analysis of the state of pharmaceutical care for patients with problems of the eyes and adnexa

Analysis of the 
pharmacoepidemiology of 

ophthalmic diseases

Analysis of the range of 
medicinal used ophthalmic 

diseases

Analysis of the 

procurement of drugs 
used in coronary artery 

disease

II Organizational and economic approaches to the study of consumers

1 Processing of statistical 

data of ophthalmic diseases

1 Marketing analysis of 

assortment
2 Graphical analysis

III Stage comparison

1. Compare actual drug consumption with actual purchases
2. Compare prescribed medicines with standa

Improving pharmaceutical care for patients with diseases of the eyes and adnexa

Studying the demand and 
actual consumption of drugs 

used in coronary artery 
disease

1 Analysis of drug procurement
2 Assessing the affordability of 
medicines
2 Assessment of the need for drugs
3. Assessment of drug 
consumption

V stage. Development of optimal pharmaceutical care for patients with diseases of the eyes and adnexa

1. Develop a program for processing statistical data on the pharmacoepidiology of morbidity

2. Predict further spread of morbidity
3. Develop a program to determine the optimal need for medicines

Stage VI Pharmacoeconomic evaluation of therapy used in ophthalmic practice

1. Conduct a systematic review of the scientific literature based on evidence-based medicine on clinical effectiveness
2. Systematic review of scientific literature on economic efficiency

3. Analysis of the cost-effectiveness of treatm

Results of the first stage:

1. Collection of basic data for analysis

Economic results of the second stage:
1. Actual spread of disease

2. The total number of the range of medicines
3. Actual volume of import of medicines

4. Actual demand and consumption of medicines
5. Accuracy and reliability of forecasting

Results of the 3rd stage:
1. Contributes to the definition of need

2. Rational use of medicines

Results of the 4th stage
1. Contributes to the formation of the list of essential medicines

2. Contributes to the improvement of treatment standards and clinical guidelines
3. Promotes rational use of the state budget

https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/index.php/ajbspi


Volume 02 Issue 12-2022 26 

                 

 
 

   
  
 

American Journal Of Biomedical Science & Pharmaceutical Innovation    
(ISSN – 2771-2753) 
VOLUME 02 ISSUE 12     Pages: 21-26 

SJIF IMPACT FACTOR (2021: 5. 705) (2022: 5. 705)  
OCLC – 1121105677    METADATA IF – 5.896 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Publisher: Oscar Publishing Services 

Servi 

The analysis of the range, pharmacoepidiology of 

patients with ophthalmic diseases was carried out, the 

case histories were studied, the analysis of the 

purchase of medicines used in ophthalmological 

practice was carried out. Based on these data, a model 

has been developed to improve pharmaceutical care 

for ophthalmic patients. The model consists of 2 levels 

of organization. The first is the medical level of the 

organization, the second is the pharmaceutical level of 

the organization. 

REFERENCES 

1. N.N. Zubov, V.I. Kuvakin. Methods of 

multivariate statistical data analysis in 

medicine and pharmacy. Tutorial. St. 

Petersburg-2017. –S.138-150. 

2. Belousova O. V., Belousov E. A., Bugaeva A. S. 

Monitoring the provision of pharmaceutical 

care to the population of the city of Belgorod // 

Scientific results of biomedical research 

3. Umarova Sh. Z., Shodmanov Sh. F., 

Sultanbayeva N. M. U. Development of a 

system management model for the process of 

providing pharmaceutical care to patients with 

diseases of the eye and adnexa // Scientific 

progress as a key factor in the development of 

the sphere of knowledge. - 2020. - S. 332-337.

 

https://doi.org/10.37547/ajbspi/Volume02Issue12-04
https://scholar.google.co.in/scholar?q=SYSTEM%20MODELING%20OF%20PHARMACEUTICAL%20CARE%20IN%20OPHTHALMOLOGICAL%20PRACTICE%20AND%20ORGANIZATIONAL%20AND%20ECONOMIC%20JUSTIFICATION%20OF%20THE%20MAIN%20DIRECTIONS%20OF%20ITS%20IMPLEMENTATION
https://www.mendeley.com/search/?page=1&query=
https://theusajournals.com/index.php/ajbspi

